4th Quarter - Amendment

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$810,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2023 $440,000 Replaced
4th Quarter - Amendment (this page) Aug 9, 2023 $810,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmacist equitable access, health equity. H.R. 7213 Clinical trial diversity, health equity. H.R. 5030/S. 2706 Emergency preparedness and response. S. 3799 Healthcare innovation, ARPA-H, oncology research. H.R. 6000 Laboratory diagnostic services, schedule reimbursement S. 4449 Omnibus federal appropriations Pandemic Response Biden Cancer Moonshot Initiative H.R.3258 Timely Access to Cancer Treatment Act. H.R.2163, S.464 The Safe Step Act. H.R. 8800 Supporting Medicare Providers Act of 2022

LobbyistCovered position, as disclosed
JOSHUA C BABB —
JASEY CARDENAS —
BEN JONES —
LISA LANGENDERFER —
DAMON SHELBY PORTER —
PETER SLONE —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7213 (117th), H.R. 3258 (117th), H.R. 6000 (117th), S. 464 (117th), H.R. 8800 (117th), H.R. 5030 (117th), S. 3799 (117th), H.R. 2163 (117th), S. 2706 (117th), S. 4449 (117th)

Medicare/Medicaid MMM

H.R.3173, S.3018 The Improving Seniors Timely Access to Care Act. H.R.7213 Pharmacist equitable access, health equity. H.R.6000 Healthcare innovation, ARPA-H, oncology research.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
JASEY CARDENAS —
BEN JONES —
LISA LANGENDERFER —
DAMON SHELBY PORTER —
PETER SLONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3018 (117th), H.R. 7213 (117th), H.R. 3173 (117th), H.R. 6000 (117th)

Pharmacy PHA

S.4449 Laboratory diagnostic services, schedule reimbursement. H.R.7213 Pharmacist equitable access, health equity. S.1909, H.R.3554 Pharmacy DIR Reform to Reduce Senior Drug Costs Act. H.R. 3258 Timely Access to Cancer Treatment.

LobbyistCovered position, as disclosed
JOSHUA C BABB —
JASEY CARDENAS —
BEN JONES —
LISA LANGENDERFER —
DAMON SHELBY PORTER —
PETER SLONE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7213 (117th), H.R. 3258 (117th), S. 4449 (117th), S. 1909 (117th), H.R. 3554 (117th)

Taxation/Internal Revenue Code TAX

S.1909, H.R.3554 Pharmacy DIR Reform to Reduce Senior Drug Costs Act H.R.5376 The Inflation Reduction Act

LobbyistCovered position, as disclosed
JASEY CARDENAS —
BEN JONES —
LISA LANGENDERFER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5376 (117th), H.R. 3554 (117th), S. 1909 (117th)

Tariff (miscellaneous tariff bills) TAR

H.R.5376 The Inflation Reduction Act

LobbyistCovered position, as disclosed
JASEY CARDENAS —
LISA LANGENDERFER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.